Immunogens For Hiv Vaccination


The full document isn't yet available to us from the patent office.


The present invention relates to novel immunogens based on overlapping peptides (OLPs) and peptides derived therefrom useful for the prevention and treatment of AIDS and its related opportunistic diseases. The invention also relates to isolated nucleic acids, vectors and host cells expressing these immunogens as well as vaccines including said immunogens.


Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Jul 31, 2013
  • Application: Jan 27, 2012
    EP EP 12382031 A
  • Priority: Jan 27, 2012
    EP EP 12382031 A

Download Citation

Sign in to the Lens